Quintiles survey finds pharma still stuck on short-termism
Creation of long-term biopharma relationships is hindered by continued pursuit of short-term gains, according to Quintiles’ New Health Report.
Archives for June 4, 2012
EMA adds formulation, closure flexibility to biosimilar guidance
The EMA has joined the FDA in proposing to accept different biosimilar formulations and closures in revised draft guidelines.
Fantastic four pool together to create super suite for processing HP drugs
Schenck Accurate, Malvern, PSL and Sturtevant have teamed up to create a “unique” new turnkey isolated milling suite which they say will wipe out unnecessary waiting times for high potency (HP) drug processing.
Cetero posts $3.1m net loss as FDA rework drags on earnings
Cetero Research posted a $3.1m (€2.5m) net loss in April as FDA rework expenses and reorganisation costs dragged on earnings.
Quicker, safer vaccine production a reality thanks to hydrogen peroxide, according to study
Hydrogen peroxide could be the key to safer and more efficient vaccine production, according to researchers at Oregon Health & Science University.
Round up of CMO M&A
Outsourcing-Pharma presents a roundup of M&A activity in the CMO space, including Piramal on the hunt for deals and Siegfried buying AMP.